Cogentin

Cogentin is a brand name of benztropine, approved by the FDA in the following formulation(s):

COGENTIN (benztropine mesylate - injectable; injection)

• 
  Manufacturer: LUNDBECK INC
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 1MG/ML ^[RLD][AP]

Has a generic version of Cogentin been approved?

Yes. The following products are equivalent to Cogentin:

benztropine mesylate injectable; injection

• 
  Manufacturer: HIKMA FARMACEUTICA
  
  Approval date: August 31, 2009
  
  Strength(s): 1MG/ML ^[AP]


• 
  Manufacturer: LUITPOLD
  
  Approval date: March 29, 2010
  
  Strength(s): 1MG/ML ^[AP]


• 
  Manufacturer: NEXUS PHARMS
  
  Approval date: July 28, 2009
  
  Strength(s): 1MG/ML ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cogentin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Cogentin.

See also...

• Cogentin Consumer Information (Wolters Kluwer)
• Cogentin Consumer Information (Cerner Multum)
• Cogentin Advanced Consumer Information (Micromedex)
• Cogentin Injection Advanced Consumer Information (Micromedex)
• Cogentin AHFS DI Monographs (ASHP)
• Benztropine Consumer Information (Wolters Kluwer)
• Benztropine Tablets Consumer Information (Wolters Kluwer)
• Benztropine Consumer Information (Cerner Multum)
• Benztropine Advanced Consumer Information (Micromedex)
• Benztropine Injection Advanced Consumer Information (Micromedex)
• Benztropine Mesylate AHFS DI Monographs (ASHP)